Home  >  Products  >  Dcaf7 (DDB1 and CUL4 associated factor 7 ) Blocking Peptide (the N terminal of Dcaf7)(100ug)
Dcaf7 (DDB1 and CUL4 associated factor 7 ) Blocking Peptide (the N terminal of Dcaf7)(100ug)

Dcaf7 (DDB1 and CUL4 associated factor 7 ) Blocking Peptide (the N terminal of Dcaf7)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-Dcaf7 Antibody (ARP52110_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Mouse
Presku: AAP52110
Size: 100ug
Weight: 38kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: Dcaf7 is involved in craniofacial development. It acts upstream of the EDN1 pathway and is required for formation of the upper jaw equivalent, the palatoquadrate. The activity required for EDN1 pathway function differs between the first and second arches. It associates with DIAPH1 and controls GLI1 transcriptional activity. It could be involved in skin development. It may function as a substrate receptor for CUL4-DDB1 E3 ubiquitin-protein ligase complex.
Alternative names: 1700012F10Rik; 2610037L01Rik; C86529; HAN11; Wdr68
See Full Product Listings >